A prescription for a Schedule H or H1 drug in India is not valid just because a doctor wrote it. It has to carry specific fields, and for the narrower Schedule H1 list, the pharmacy filling it has a separate record-keeping obligation that runs for three years. Most clinics get the clinical part right without thinking about it and get the paperwork part wrong without noticing, because nothing forces the gap into view until an inspection does. This is what the rule actually requires, and what a digital prescription flow can structurally enforce versus what stays the doctor's call.
Schedule H and Schedule H1 are lists of drugs under India's Drugs and Cosmetics Rules, 1945 that cannot be sold over the counter. Rule 65(9)(a) states that drugs specified in Schedule H, Schedule H1, or Schedule X may not be sold by retail except on and in accordance with the prescription of a Registered Medical Practitioner. That single line is the baseline every clinic, and every pharmacy filling that prescription, is working from.
Schedule H1 is a narrower list added by Gazette notification G.S.R. 588(E) dated 30 August 2013, introduced specifically to curb indiscriminate use of a defined set of drugs: certain third and fourth generation antibiotics (for example ceftriaxone and cefixime), habit-forming drugs (for example alprazolam, diazepam, and tramadol), and anti-TB drugs (for example rifampicin and isoniazid). The list runs to roughly 46 drugs. Splitting it out from Schedule H was about tighter record-keeping on these specific drugs, not a different sale restriction.
| Schedule H | Schedule H1 | |
|---|---|---|
| Sale restriction | Only against an RMP prescription | Only against an RMP prescription |
| Separate sale register required | No | Yes, a dedicated H1 register |
| Original prescription retained by seller | Not mandated | Generally yes, not returned to the patient |
| Record retention period | Not separately mandated | 3 years, open to inspection |
| Typical drug categories | Broad list of non-OTC prescription drugs | Select antibiotics, habit-forming drugs, anti-TB drugs, added via G.S.R. 588(E), 2013 |
At minimum, a valid prescription identifies the prescribing doctor by name and registration number issued by the relevant State Medical Council, carries the date, identifies the patient, states the drug's name, strength, dose and duration, and carries the doctor's signature, physical or digital. For Schedule H and H1 drugs specifically, the label the pharmacist dispenses against also has to carry the 'Rx' symbol and the statutory warning text set out in the rules.
None of this changes because a prescription is generated on a screen instead of a pad. What an inspector, or a pharmacist deciding whether to fill it, actually checks is whether those fields are present and legible, not which device produced the document.
Schedule H1 adds an obligation on top of the sale restriction: whoever supplies the drug at retail has to log that supply in a separate register at the time of sale, capturing the prescriber's name and address, the patient's name, the drug name, and the quantity supplied. That register has to be kept for three years and be available for inspection on request. The original prescription for an H1 drug is generally meant to be retained by the seller rather than handed back to the patient, which is a different practice from most Schedule H dispensing.
This is a record-keeping duty that sits with whoever actually dispenses the drug, an in-house pharmacy or an outside chemist, not with whatever generated the prescription in the first place. A clinic that writes a compliant prescription but has no register on the dispensing side has only closed half the gap.
Software can capture and structure the fields a valid prescription needs. It cannot exercise the clinical judgement of whether a given Schedule H1 drug is the right call for a specific patient, and it does not verify that a doctor's registration is currently valid with their State Medical Council. Both of those stay the doctor's responsibility, the same as they would with a paper prescription pad.
Schedule X drugs, narcotic and psychotropic substances under stricter separate control, are not covered by anything in this article. Do not assume Schedule H1 handling is sufficient for a Schedule X drug.
If a clinic sends patients to an external pharmacy rather than dispensing through CuraVerto's own Pharmacy add-on, the H1 register obligation sits with that external pharmacy. CuraVerto's prescription record is not a substitute for the seller's own register.
Digital Rx with WhatsApp delivery and the mandatory prescriber registration-number field are on CuraVerto's Essential plan at โน9,999 per year, the entry tier, alongside GST billing and the WhatsApp booking bot.
With CuraVerto: Full audit-log visibility, who changed a prescription, when, and what it looked like before and after, is part of Plus at โน49,999 per year.
The Pharmacy module, including the Schedule H/H1 Drug Register report, is a real add-on that bolts onto Pro or Plus, priced separately, built for clinics dispensing on site rather than sending patients to an outside chemist.
Both can only be sold against a Registered Medical Practitioner's prescription, under Rule 65(9)(a) of the Drugs and Cosmetics Rules, 1945. Schedule H1 is a narrower list added in 2013 covering certain third and fourth generation antibiotics, habit-forming drugs, and anti-TB drugs, and it adds obligations Schedule H alone does not: the seller must keep a separate register of every H1 sale and generally retain the original prescription rather than return it to the patient.
At minimum: the prescribing doctor's name and registration number, the date, identification of the patient, the name, strength, dose and duration of the drug, and the doctor's signature, physical or digital. This baseline does not change because the prescription was generated digitally instead of handwritten.
Three years, and they have to be open for inspection. The obligation sits with whoever sells the drug at retail, typically a pharmacist, and covers the prescriber's name and address, the patient's name, the drug name, and the quantity supplied, logged in a separate H1 register at the time of sale.
The channel a prescription is delivered through is a separate question from whether the document itself is valid. What matters for Schedule H and H1 purposes is whether the required fields, prescriber registration number, date, patient identification, drug details, and signature, are present and legible, on paper or on screen. See CuraVerto's separate piece on what has to be on a prescription sent over WhatsApp for the delivery-channel side of this.
No, and it is worth being direct about that. Software can make sure a prescription cannot be created without a prescriber registration number, that every prescription is tied to a specific dated patient record, and that dispensing records exist for later inspection. It cannot exercise clinical judgement about whether a given drug is right for a given patient, and it does not verify that a doctor's registration is currently valid with their State Medical Council. That remains the doctor's responsibility.
Digital Rx with the mandatory prescriber registration-number field is on Essential, CuraVerto's entry plan at โน9,999 per year. The Schedule H/H1 Drug Register report, generated from dispensing records, is part of CuraVerto's in-house Pharmacy add-on, which bolts onto Pro or Plus and is for clinics dispensing on site rather than sending patients to an outside chemist.
Digital Rx with a mandatory prescriber registration number and WhatsApp delivery is on CuraVerto's Essential plan at โน9,999 per year. The in-house Pharmacy add-on, which generates the Schedule H/H1 drug register report, bolts onto Pro or Plus for clinics dispensing on site.